Replies to post #10707 on Vystar Corp (VYST)

[MMMQA]

Vystar Debuts Enhanced RxAir® UV Light Air Purifiers to Fight Flu, Colds & Airborne Germs
Features longer-lasting, more effective UV light for more efficient inactivation of viruses and bacteria
RxAir available for medical, business and residential
RxAir now available via Vystar’s medical distributors
Effective purification of 1000 sq. ft. space with 3.2 passes/hr.
WORCESTER, Mass., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Vystar Corp. (OTC Market: VYST) announced today that new and improved RxAir® UV Light Air Purifiers are now available to combat cold, flu and other airborne germs that are more pervasive during the winter. Vystar acquired RxAir approximately nine months ago and immediately began upgrading the air purifiers to improve performance and longevity. The first upgraded RxAir units are now available for purchase via RxAir.com, Rotmans.com, Rotmans Furniture & Carpet in Worcester, Mass., and RxAir medical distributors.

New and improved RxAir UV light air purifier features longer-lasting, more effective UV light for more efficient inactivation of more than 99% of germs on first pass


RxAir - The air purifier trusted by hospitals


New units now available feature a higher grade UV light bulb that lasts longer and produces longer UV wave length for more efficient killing/inactivation of bacteria, germs and other pathogens. The new units also offer improved alert codes to more easily identify when action, such as replacing a bulb cartridge, is needed.

Hospitals and healthcare facilities have been using industrial size UV light air purification systems for airborne infection control because they have been proven to inactivate a broad array of airborne viruses and bacteria, including influenza and cold viruses.

“Flu vaccines only protect you from a few flu strains and none of them protect you from the common cold and many other illnesses,” stated Bryan Stone, MD, Internal Medicine and Nephrology, Chief of Medicine for Desert Regional Medical Center. “Using UV light to kill airborne germs has been proven as an effective hospital infection control technology for years. The new RxAir now provides an even more effective way to bring this technology into your home or office to reduce your exposure to these pathogens to help avoid infection.”

Dr. Stone discusses how RxAir works in this video.

“As the new owners of RxAir, Vystar is excited to make RxAir available to the public once again — now in a new and improved format — as we enter the peak cold and flu season period,” stated Steve Rotman, Vystar CEO. “We feel it is critical to have a proven germ killing technology that is relied upon by hospitals to be available for purchase online so homes, schools, restaurants, retail stores and medical offices nationwide can reduce the risk of spreading airborne illnesses.”

RxAir is one of the few UV air purifiers that have been proven in independent EPA- and FDA-certified testing laboratories to destroy on first pass more than 99% of harmful viruses and bacteria. In addition to inactivating airborne viruses that cause influenza and colds, RxAir disarms the airborne pathogens that cause MRSA (staph), strep (whooping cough), tuberculosis (TB), measles, pneumonia and a myriad of other antibiotic-resistant and viral infections.

“For years, there has been so much emphasis placed on surface disinfection, but we really need to address the primary way you catch the flu and colds,” noted Dr. Stone.

People primarily spread flu viruses by coughing, sneezing, or talking, which creates tiny droplets that carry the flu viruses, according to the CDC. These droplets can land in the mouths, noses or eyes of people who are nearby or possibly be inhaled into the lungs where they can more easily cause infection. Less often, a person might also get flu by touching an object that has flu virus on it and then touching their mouth, nose or eyes.

“When a person infected with the flu, pneumonia, strep or a cold -- even in the asymptomatic incubation stage -- enters a room and talks, sneezes or coughs, they contaminate the space regardless of any sanitization that already occurred,” Dr. Stone explained. “UV air purifiers are the best way to combat airborne pathogens on a continuous basis.”

“If I were creating the most effective defense against seasonal flu, I would want a quality device that works continuously over a large area, across all flu viruses and is tested to perform effectively over a long period of time,” stated Dr. Stone. “The RxAir device does this, as proven in independent laboratory testing. RxAir, in concert with vaccination, hand washing and avoidance of sick people, gives you the best fighting chance to reduce your exposure to cold, flu and many other airborne transmitted illnesses, such as pneumonia, TB, measles, strep, and MRSA.”

The RxAir Air Purifier’s patented kill chamber, which prolongs exposure to industrial-strength, high-intensity UV-C lights, and powerful air flow capacity continually inactivate more than 99% of many types of airborne bacteria and viruses as they are produced, helping to prevent inhalation and thereby infection, for everyone in the room, whether they’ve been vaccinated with the present influenza strain or not. RxAir’s powerful air circulation purifies all air in a 1000 sq. ft. room with 3.2 passes per hour – a significantly higher capacity that most competitors’ air purifiers.

RxAir is currently expanding its network of RxAir medical distributors. For information on becoming an RxAir retailer or distributors, contact [e-mail].